| Factor Information | |
|---|---|
| Data ID | 3231 |
| Factor | association between Apgar score and CVP score after controlling for variables |
| Description | N/A |
| Biomarker | NA |
| Classification | Z (combined factor - combined factor) |
| Association | |
|---|---|
| Application | risk assessment and prognosis |
| Objective | Congestive heart failure in fetuses with congenital heart defects (CHD) is associated with high perinatal mortality. The clinical condition can be characterized by five ultrasound markers that comprise the 10-point cardiovascular profile (CVP) score. Our aim was to assess the value of the CVP score in evaluating the condition and in maintaining surveillance of fetuses with CHD. |
| p Value | 0.013 |
| OR | 14.1 |
| Conclusion | Fetuses with CHD and a CVP score below 8 are at risk of perinatal death. The CVP score may be used to assess the severity of fetal CHD and to plan perinatal management. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 664 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | HLHS/HRHS/TA/DILV/DORV, MA/SILV/AA/AS, PS/AVC, PS/TOF/TGA/DORV/AVC/VSD/SASD/APVR/EA/PA/TVD/CoA/AS/IAA/RAI |
| Reference | |
|---|---|
| PMID | 18253925 |
| Year | 2008 |
| Title | Prediction of outcome of fetal congenital heart disease using a cardiovascular profile score |
| Sample | ||
|---|---|---|
| Population | fetuses | |
| Source | patients' data | |
| Region | Florida, America | |
| Method | multivariate logistic regression | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | patients with CVP score of <=7 or >=8(Treatment) | dichotomized 5-min Apgar scores(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
